Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Vaccines for tumour prevention.

Lollini PL, Cavallo F, Nanni P, Forni G.

Nat Rev Cancer. 2006 Mar;6(3):204-16. Review.

PMID:
16498443
2.

Prevention of cancer through immunization: Prospects and challenges for the 21st century.

Frazer IH, Lowy DR, Schiller JT.

Eur J Immunol. 2007 Nov;37 Suppl 1:S148-55. Review.

3.

Vaccines: an innovative approach to treating cancer.

Pazdur MP, Jones JL.

J Infus Nurs. 2007 May-Jun;30(3):173-8. Review.

PMID:
17505219
4.

Unmet need in lung cancer: can vaccines bridge the gap?

Kim J, Raz D, Jablons D.

Clin Lung Cancer. 2008 Feb;9 Suppl 1:S6-12. Review.

PMID:
18540529
5.

Vaccination for treatment and prevention of cancer in animal models.

Cavallo F, Offringa R, van der Burg SH, Forni G, Melief CJ.

Adv Immunol. 2006;90:175-213. Review.

PMID:
16730264
6.

Cancer vaccines: preclinical studies and novel strategies.

Palena C, Abrams SI, Schlom J, Hodge JW.

Adv Cancer Res. 2006;95:115-45. Review.

PMID:
16860657
7.

Vaccine therapy for melanoma: current status and future directions.

Terando AM, Faries MB, Morton DL.

Vaccine. 2007 Sep 27;25 Suppl 2:B4-16. Epub 2007 Jul 5. Review.

PMID:
17646038
9.

Is vaccine therapy the future in cancer prevention?

Frazer I.

Expert Opin Pharmacother. 2004 Dec;5(12):2427-34.

PMID:
15571460
10.

Promising particle-based vaccines in cancer therapy.

Xiang SD, Scalzo-Inguanti K, Minigo G, Park A, Hardy CL, Plebanski M.

Expert Rev Vaccines. 2008 Sep;7(7):1103-19. doi: 10.1586/14760584.7.7.1103. Review.

PMID:
18767957
11.

Prostate cancer: genes, environment, immunity and the use of immunotherapy.

Karan D, Thrasher JB, Lubaroff D.

Prostate Cancer Prostatic Dis. 2008;11(3):230-6. doi: 10.1038/pcan.2008.3. Epub 2008 Feb 19. Review.

PMID:
18283297
12.

Allogeneic and autologous melanoma vaccines: where have we been and where are we going?

Sondak VK, Sabel MS, Mulé JJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2337s-2341s. Review.

13.

Prospects for vaccine therapy for pancreatic cancer.

Gaudernack G.

Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):299-314. Review.

PMID:
16549329
14.

Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?

Iero M, Filipazzi P, Castelli C, Belli F, Valdagni R, Parmiani G, Patuzzo R, Santinami M, Rivoltini L.

Cancer Immunol Immunother. 2009 Jul;58(7):1159-67. doi: 10.1007/s00262-008-0610-6. Epub 2008 Nov 8.

PMID:
18998128
15.

Tissue vaccines for cancer.

Suckow MA, Heinrich J, Rosen ED.

Expert Rev Vaccines. 2007 Dec;6(6):925-37. doi: 10.1586/14760584.6.6.925. Review.

PMID:
18377356
16.

New advances in vaccine technology and improved cervical cancer prevention.

Huh WK, Kendrick JE, Alvarez RD.

Obstet Gynecol. 2007 May;109(5):1187-92.

PMID:
17470604
17.
18.

Current progress of DNA vaccine studies in humans.

Lu S, Wang S, Grimes-Serrano JM.

Expert Rev Vaccines. 2008 Mar;7(2):175-91. doi: 10.1586/14760584.7.2.175. Review.

PMID:
18324888
19.

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.

Aptsiauri N, Carretero R, Garcia-Lora A, Real LM, Cabrera T, Garrido F.

Cancer Immunol Immunother. 2008 Nov;57(11):1727-33. doi: 10.1007/s00262-008-0532-3. Epub 2008 May 20. Review.

PMID:
18491093
20.

DNA vaccination and gene therapy: optimization and delivery for cancer therapy.

Bodles-Brakhop AM, Draghia-Akli R.

Expert Rev Vaccines. 2008 Sep;7(7):1085-101. doi: 10.1586/14760584.7.7.1085. Review.

PMID:
18767956

Supplemental Content

Support Center